Jarushka Naidoo

Jarushka graduated with her medical degree from Trinity College Dublin, and completed  internal medicine and a medical oncology training through the Royal College of Physicians of Ireland. She completed an awarded advanced medical oncology fellowship at Memorial Sloan Kettering Cancer Center (New York) and joined the faculty at Johns Hopkins University from 2015-2020. At Johns Hopkins, she led a portfolio of clinical trials and translational studies focused on immunotherapy for lung cancer and immune-related toxicity. Dr. Naidoo led several investigator-initiated trials for patients with lung cancer, with a focus on stage III non-small lung cancer and CNS metastases. She is a globally recognised leader in the field of immune-related toxicity, with >100 publications in this field, and her development of the multidisciplinary Johns Hopkins Immune-related Toxicity Team. She is the recipient of several grants and awards including a US NIH KL2 Clinical Scholar Award, Lung Cancer Foundation of America/IASLC Young Investigator Award.
Since her return to Ireland, Jarushka serves as the Chair of the Lung Cancer Disease-specific subgroup (DSSG) of Cancer Trials Ireland, is the Founder and Chair of the Irish national lung cancer research group, the ‘Irish Lung Cancer Alliance,’ and a national immmunotherapy toxicity network through the RCPI. She is currently a part of the ETOP, EORTC, ECOG-ACRIN and NRG Cooperative clinical trial groups, and the clinical trials portfolio in lung cancer has tripled since her return. Prof Naidoo was named the Irish Cancer Society’s Clinician Research Leader Award 2021.